HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
302.76
-1.86 (-0.61%)
Dec 26, 2024, 4:00 PM EST - Market closed
HCA Healthcare Analyst Ratings
Total Analysts
15
Consensus Rating
Buy
Price Target
$381.29
Upside
+25.94%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $406 → $355 | Hold | Maintains | $406 → $355 | +17.25% | Dec 17, 2024 |
| JP Morgan | JP Morgan | Hold Initiates $380 | Hold | Initiates | $380 | +25.51% | Dec 17, 2024 |
| Wells Fargo | Wells Fargo | Hold → Sell Downgrades $400 → $320 | Hold → Sell | Downgrades | $400 → $320 | +5.69% | Nov 25, 2024 |
| Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 22, 2024 |
| Barclays | Barclays | Buy Maintains $396 → $392 | Buy | Maintains | $396 → $392 | +29.48% | Nov 8, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $395 → $400 | Hold | Maintains | $395 → $400 | +32.12% | Nov 6, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $450 → $440 | Strong Buy | Maintains | $450 → $440 | +45.33% | Oct 28, 2024 |
| Keybanc | Keybanc | Buy Maintains $475 → $420 | Buy | Maintains | $475 → $420 | +38.72% | Oct 28, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $390 → $400 | Buy | Maintains | $390 → $400 | +32.12% | Oct 28, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $365 → $395 | Hold | Maintains | $365 → $395 | +30.47% | Oct 22, 2024 |
| Keybanc | Keybanc | Buy Initiates $475 | Buy | Initiates | $475 | +56.89% | Oct 11, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $392 | Buy | Reiterates | $392 | +29.48% | Oct 4, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $392 | Buy | Reiterates | $392 | +29.48% | Oct 1, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $427 | Hold | Initiates | $427 | +41.04% | Sep 3, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $378 → $405 | Buy | Maintains | $378 → $405 | +33.77% | Aug 23, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $392 | Buy | Reiterates | $392 | +29.48% | Aug 20, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.